Marie-Laure Kürzinger

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Pulmonary Embolism

Risk Assessment

Decision Making

Top Venues

Journal of medical Internet research

Therapeutic advances in drug safety

Health expectations : an international journal of public participation in health care and health policy

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Marie-Laure Kürzinger, Chantal El-Haddad, Tatiana Gouin-Soboleva, Zita Fazekas, Denis Granados, Elizabeth Benito-Garcia, Yasmina Djoudi
Structured benefit-risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer. Pharmacoepidemiology and drug safety 33 (5) (2024)
Marie-Laure Kürzinger, Ludivine Douarin, Ievgeniia Uzun, Chantal El-Haddad, William Hurst, Juhaeri Juhaeri, Stéphanie Tcherny-Lessenot
Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature. Therapeutic advances in drug safety 11 (2020)
Lidewij Eva Vat, Teresa M D Finlay, Tjerk Jan Schuitmaker-Warnaar, Nick Fahy, Paul Robinson, Mathieu Boudes, Ana Diaz, Elisa Ferrer, Virginie Hivert, Gabor Purman, Marie-Laure Kürzinger, Robert A Kroes, Claudia Hey, Jacqueline E W Broerse
Evaluating the "return on patient engagement initiatives" in medicines research and development: A literature review. Health expectations : an international journal of public participation in health care and health policy 23 (1) (2019)
Marie-Laure Kürzinger, Stéphane Schuck, Nathalie Texier, Redhouane Abdellaoui, Carole Faviez, Julie Pouget, Ling Zhang, Stéphanie Tcherny-Lessenot, Stephen Lin, Juhaeri Juhaeri
Web-Based Signal Detection Using Medical Forums Data in France: Comparative Analysis. Journal of medical Internet research 20 (11) (2018)